Advertisement
Danaher Corporation

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DHRNYSE
HealthcareMedical - Diagnostics & Research
$180.44
$3.09(1.68%)
U.S. Market is Open · 13:49
Advertisement

Danaher Corporation (DHR)

Meyka AI Score

Z

Key Financials

Market Cap133.4B
P/E Ratio35.24
EPS (TTM)$5.16
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

DHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.03, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.24 and a market capitalization of 133.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.54%
5-Day Change
-2.32%
1-Month Change
7.29%
3-Month Change
-5.94%
6-Month Change
-20.31%
Year-to-Date (YTD) Change
-19.78%
1-Year Change
-9.37%
3-Year Change
-12.98%
5-Year Change
-15.88%
All-Time (Max) Change
30725.40%

Contact Information

202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

610,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions